MedPath

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia
Ownership
-
Established
1876-01-01
Employees
19.4K
Market Cap
-
Website
https://www.jhu.edu/

The Depression in Alzheimer's Disease Study (DIADS)

Phase 4
Completed
Conditions
Alzheimer Disease
Depression
First Posted Date
2001-01-24
Last Posted Date
2018-08-20
Lead Sponsor
Johns Hopkins University
Registration Number
NCT00009191
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Psychological Treatments for Scleroderma

Phase 2
Completed
Conditions
Depression
Systemic Sclerosis
Pain
Scleroderma
Interventions
Behavioral: Self-help cognitive behavioral intervention facilitated by a psychologist
Behavioral: Cognitive behavioral therapy
Behavioral: Disease/health education
First Posted Date
2000-12-18
Last Posted Date
2017-08-09
Lead Sponsor
Johns Hopkins University
Target Recruit Count
89
Registration Number
NCT00007267
Locations
🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Naltrexone Treatment for Alcoholism

Phase 4
Completed
Conditions
Alcoholism
First Posted Date
1999-11-03
Last Posted Date
2010-05-14
Lead Sponsor
Johns Hopkins University
Target Recruit Count
192
Registration Number
NCT00000438
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis

Not Applicable
Completed
Conditions
Epilepsy
Cysticercosis
First Posted Date
1999-10-19
Last Posted Date
2015-03-25
Lead Sponsor
Johns Hopkins University
Target Recruit Count
120
Registration Number
NCT00004403
© Copyright 2025. All Rights Reserved by MedPath